Qiu Yuyue, Shao Xiaoni
College of Pharmacy and Food, Southwest Minzu University, Chengdu, Sichuan, 610225, People's Republic of China.
Drug Des Devel Ther. 2025 Jul 29;19:6435-6459. doi: 10.2147/DDDT.S524008. eCollection 2025.
Histone lactylation, as a common post-translational modification (PTM), is crucial in diseases. Aberrant histone lactylation has been linked to disease pathogenesis, thus positioning it as a therapeutic target. This review summarizes the bidirectional relationship between histone lactylation and diseases, emphasizing how Traditional Chinese medicine (TCM) regulates lactate levels to restore histone lactylation homeostasis. Mechanistically, TCM modulates histone lactylation through dual regulation of lactyltransferases and lactate metabolism, thereby influencing disease progression in inflammatory, metabolic, and neoplastic disorders. Notably, TCM is characterized by unique advantages of cost-effectiveness, high efficacy, and minimal adverse effects. For diseases with established drug resistance, TCM offers a promising therapeutic alternative in managing drug-resistant illness by regulating histone lactylation. This review is conducive to understanding the relationship between histone lactylation and disease. TCM effectively treats diseases through the regulation of histone lactylation, thereby highlighting its potential for disease treatment application.
组蛋白乳酸化作为一种常见的翻译后修饰(PTM),在疾病中至关重要。异常的组蛋白乳酸化与疾病发病机制相关,因此将其定位为一个治疗靶点。本综述总结了组蛋白乳酸化与疾病之间的双向关系,强调了中药(TCM)如何调节乳酸水平以恢复组蛋白乳酸化稳态。从机制上讲,中药通过对乳酸转移酶和乳酸代谢的双重调节来调节组蛋白乳酸化,从而影响炎症、代谢和肿瘤性疾病的疾病进展。值得注意的是,中药具有成本效益高、疗效好和不良反应最小的独特优势。对于已产生耐药性的疾病,中药通过调节组蛋白乳酸化在治疗耐药性疾病方面提供了一种有前景的治疗选择。本综述有助于理解组蛋白乳酸化与疾病之间的关系。中药通过调节组蛋白乳酸化有效治疗疾病,从而突出了其在疾病治疗应用中的潜力。
Drug Des Devel Ther. 2025-7-29
Front Immunol. 2025-6-27
Phytomedicine. 2024-7-25
Neural Regen Res. 2025-6-19
Proc Natl Acad Sci U S A. 2025-2-18
J Ethnopharmacol. 2025-1-31
J Mol Cell Biol. 2025-5-22
Nat Immunol. 2024-11